Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10010510996
waren, mit denen die dedizierten Biotechnologie-Unternehmen in Deutschland in den Jahren 1999-2009 zu kämpfen hatten. Die … Biotechnologiefirmen in Deutschland, der Nachfolger BioChancePlus erreichte 40% seiner Zielgruppe. Insgesamt erhielten 260 Unternehmen eine …
Persistent link: https://www.econbiz.de/10009561494
Der vorliegende Bericht stellt die Ergebnisse einer Systemevaluierung der Förderinitiative KMU-innovativ des BMBF dar. Die Evaluierung startete Ende 2008 und damit ein Jahr nach dem Beginn der Förderinitiative im Herbst 2007. Sie hatte zum Ziel, die Implementation, Zielerreichung und Wirkung...
Persistent link: https://www.econbiz.de/10009541838
Persistent link: https://www.econbiz.de/10011453476
COVID-19 placed a special role to fiscal policy in rescuing companies short of liquidity from insolvency. In the first months of the crisis, SMEs as the backbone of Europe’s real economy benefited from large and mainly indiscriminate aid measures. Avoiding business failures in a whatever it...
Persistent link: https://www.econbiz.de/10012434436
COVID-19 placed a special role to fiscal policy in rescuing companies short of liquidity from insolvency. In the first months of the crisis, SMEs as the backbone of Europe’s real economy benefited from large and mainly indiscriminate aid measures. Avoiding business failures in a whatever it...
Persistent link: https://www.econbiz.de/10013239593
COVID-19 placed a special role to fiscal policy in rescuing companies short of liquidity from insolvency. In the first months of the crisis, SMEs as the backbone of Europe’s real economy benefited from large and mainly indiscriminate aid measures. Avoiding business failures in a whatever it...
Persistent link: https://www.econbiz.de/10013245420
Persistent link: https://www.econbiz.de/10000554251
Persistent link: https://www.econbiz.de/10001297936
Persistent link: https://www.econbiz.de/10001336813